These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33868488)

  • 21. Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.
    Zhou C; Ren S; Zhou S; Zhang L; Su C; Zhang Z; Deng Q; Zhang J
    Jpn J Clin Oncol; 2010 Oct; 40(10):954-60. PubMed ID: 20462983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Strong Relationship Between Oral Squamous Cell Carcinoma and DNA Repair Genes.
    Avci H; Ergen A; Bireller ES; Ertugrul B; Cakmakoglu B
    Biochem Genet; 2017 Dec; 55(5-6):378-386. PubMed ID: 28639054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased steady state mRNA levels of DNA-repair genes XRCC1, ERCC2 and ERCC3 in brain of patients with Down syndrome.
    Fang-Kircher SG; Labudova O; Kitzmueller E; Rink H; Cairns N; Lubec G
    Life Sci; 1999; 64(18):1689-99. PubMed ID: 10328528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer.
    Geredeli C; Artac M; Yildirim S; Inal A; Dede I; Guler T; Boruban MC; Koral L; Karaagac M; Zamani AG; Altinok T; Aribas O; Bozcuk H; Demirkazik A
    Tumour Biol; 2015 Jun; 36(6):4279-85. PubMed ID: 25596702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling.
    Yacoub A; McKinstry R; Hinman D; Chung T; Dent P; Hagan MP
    Radiat Res; 2003 Apr; 159(4):439-52. PubMed ID: 12643788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin ototoxicity in children: risk factors and its relationship with polymorphisms of DNA repair genes ERCC1, ERCC2, and XRCC1.
    Turan C; Kantar M; Aktan Ç; Kosova B; Orman M; Bilgen C; Kirazlı T
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1333-1338. PubMed ID: 31586226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion.
    Yacoub A; Park JS; Qiao L; Dent P; Hagan MP
    Int J Radiat Biol; 2001 Oct; 77(10):1067-78. PubMed ID: 11682011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
    Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis.
    Bišof V; Zajc Petranović M; Rakušić Z; Samardžić KR; Juretić A
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2305-17. PubMed ID: 26179868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of ERCC2 Gene Polymorphisms on OSCC Susceptibility and Clinical Characteristics.
    Tejasvi MA; Maragathavalli G; Kumar PU; Ramakrishna M; Raghavan V; Ck AA
    Glob Med Genet; 2020 Dec; 7(4):121-127. PubMed ID: 33693445
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
    Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients.
    Schena M; Guarrera S; Buffoni L; Salvadori A; Voglino F; Allione A; Pecorari G; Ruffini E; Garzino-Demo P; Bustreo S; Consito L; Bironzo P; Matullo G
    DNA Repair (Amst); 2012 Apr; 11(4):374-80. PubMed ID: 22284908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA repair gene ERCC1 C118T polymorphism predicts sensitivity of recurrent esophageal cancer to radiochemotherapy in a Chinese population.
    Yu X; Xiao H; Zhao B; Zhang X; Wang G
    Thorac Cancer; 2015 Nov; 6(6):741-8. PubMed ID: 26557912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERCC1, XPF and XPA-locoregional differences and prognostic value of DNA repair protein expression in patients with head and neck squamous cell carcinoma.
    Prochnow S; Wilczak W; Bosch V; Clauditz TS; Muenscher A
    Clin Oral Investig; 2019 Aug; 23(8):3319-3329. PubMed ID: 30498981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA repair gene excision repair cross complementing-group 1 (ERCC1) in head and neck squamous cell carcinoma: analysis of methylation and polymorphism (G19007A), protein expression and association with epidemiological and clinicopathological factors.
    Lima LM; de Souza LR; da Silva TF; Pereira CS; Guimarães AL; de Paula AM; de Andrade Carvalho H
    Histopathology; 2012 Feb; 60(3):489-96. PubMed ID: 22176134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
    Obiedat H; Alrabadi N; Sultan E; Al Shatti M; Zihlif M
    BMC Med Genet; 2018 Jul; 19(1):112. PubMed ID: 29980176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic implication of ERCC1 protein expression in resected oropharynx and oral cavity cancer.
    An HJ; Jo H; Jung CK; Kang JH; Kim MS; Sun DI; Cho KJ; Cho JH; Won HS; Sun S; Ko YH
    Pathol Res Pract; 2017 Aug; 213(8):949-955. PubMed ID: 28645807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.
    Pérez-Ramírez C; Cañadas-Garre M; Alnatsha A; Villar E; Valdivia-Bautista J; Faus-Dáder MJ; Calleja-Hernández MÁ
    Pharmacogenomics J; 2019 Apr; 19(2):164-177. PubMed ID: 29662106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA base excision repair proteins APE-1 and XRCC-1 are overexpressed in oral tongue squamous cell carcinoma.
    Santana T; Sá MC; de Moura Santos E; Galvão HC; Coletta RD; Freitas RA
    J Oral Pathol Med; 2017 Aug; 46(7):496-503. PubMed ID: 27925687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of DNA repair genes in oral squamous cell carcinoma using reverse transcription-quantitative polymerase chain reaction.
    Oliveira Alves MG; da Silva Miguel N; Ferreira CCP; Alvarenga ER; Tonon BM; de Barros PP; Carta CFL; Paschoal MBN; de Sales Chagas JF; Bandeira CM; Nunes FD; Almeida JD
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Sep; 130(3):298-305. PubMed ID: 32682592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.